MetaCap

Aurora Cannabis (ACB) vs Canopy Growth (CGC)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Aurora Cannabis (ACB) has outperformed Canopy Growth (CGC) over the past year, losing 1.2% versus a loss of 61.5%. Over five years, ACB leads with a -93.9% price change compared with -99.6% for CGC. Aurora Cannabis is the larger company by market cap ($273.5 million vs $192.0 million), about 1.4 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

ACB-1.19%CGC-61.53%
+80%+6%-68%
Nov 21, 20251 yearNov 20, 2026
ACB-94.09%CGC-99.65%
+5%-50%-105%
Nov 15, 20215 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

ACB versus CGC key metrics
MetricACBCGC
Share price$4.16$0.427
Market cap$273.50M$191.99M
1-day change-2.35%-9.97%
YTD return-1.42%-62.54%
1-year return-1.19%-61.53%
5-year return-93.87%-99.63%
EPS (TTM)$-0.19$-0.51
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
52-week high$6.36$2.38
52-week low$2.56$0.427
Distance from 52-week high-34.59%-82.06%
Analyst consensusunderperformbuy
Avg. price target upside—+110.77%
Average volume1.31M2.59M
Shares outstanding65.74M423.35M
Employees1,0281,128
SectorHealth CareHealth Care
Industry Medicinal Chemicals and Botanical Products Medicinal Chemicals and Botanical Products

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • ACB has outperformed CGC by 60.3 percentage points over the past year.

About Aurora Cannabis

ACB stock →

Aurora Cannabis Inc., together with its subsidiaries, engages in the production, distribution, and sale of cannabis products in Canada and internationally. The company offers pharmaceutical-grade cannabis products; and medical and consumer cannabis products.

Health Care · Medicinal Chemicals and Botanical Products · 1,028 employees

About Canopy Growth

CGC stock →

Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and cannabis-related products for medical and adult use in Canada, Germany, the United States, and internationally. The company operates through two segments, Cannabis and Storz & Bickel.

Health Care · Medicinal Chemicals and Botanical Products · 1,128 employees

ACB vs CGC FAQ

Which is bigger, Aurora Cannabis or Canopy Growth?

Aurora Cannabis (ACB) is larger, with a market capitalization of $273.50M compared with $191.99M for Canopy Growth (CGC).

Which stock has performed better over the past year, ACB or CGC?

ACB returned -1.19% over the past 12 months, compared with -61.53% for CGC (price return, excluding dividends). Past performance does not predict future results.

Are Aurora Cannabis and Canopy Growth in the same industry?

Yes. Both are classified in the Medicinal Chemicals and Botanical Products industry within the Health Care sector.

More comparisons